Global Amyotrophic Lateral Sclerosis Treatment Market
Sizing, Segmentation, & Growth Forecast (2025-2030)
Last updated: July 2026
Report Scope: The downloadable datasheet contains market sizes in USD for the period 2025-30.
Market Breakdown: Sizes and growth rates are broken down by geography and market segment (see below for details).
1. Summary
The Global Amyotrophic Lateral Sclerosis Treatment Market was valued at $820 mn. in 2025. During the forecast period 2025-2030, it is expected to grow at 6.8% CAGR, to an estimated market size of $1.1 bn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.
2. Market Definition
The Amyotrophic Lateral Sclerosis (ALS) Treatment Market encompasses the development, distribution, and administration of therapeutic interventions – including pharmacological medications, stem cell therapies, and multidisciplinary management strategies – designed to slow disease progression, manage symptoms, and improve the quality of life for patients suffering from this progressive neurodegenerative disorder.
3. Trends & Demand Drivers
Several key trends are expected to significantly impact the Amyotrophic Lateral Sclerosis Treatment Market in the period 2025-30:
- Significant advancements in gene therapy targeting specific mutations like SOD1 (e.g., Tofersen) are shifting the market toward personalized medicine.
- The rising global prevalence of ALS, driven by aging populations and improved diagnostic capabilities, is a primary driver for market expansion.
- A shift toward oral drug formulations, such as Radicava ORS, is improving patient compliance and driving revenue in the medication segment.
- Increased biomarker discovery is enabling earlier diagnosis and more effective monitoring of disease progression in clinical trials.
- The market is heavily influenced by regulatory outcomes and the success of late-stage pipeline therapies like Ibudilast and NurOwn.
- Growing global advocacy and supportive healthcare policies are fostering increased R&D investment from major pharmaceutical players.
- The adoption of multidisciplinary care models is centralizing treatment within hospital pharmacies and specialty clinics.
4. Market Breakdown
The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments:
Geographies
- North America
- Europe
- Asia-Pacific
- Rest of World
Segments
- Pharmacological Medications
- Stem Cell & Gene Therapies
- Symptomatic & Supportive Care